A recent 340B Report article from Luke Zarzecki highlights the ongoing efforts in Washington, D.C., to preserve the 340B drug pricing program for health centers and other safety-net providers. While some lawmakers are exploring 340B reforms, including rebate models and the proposed 340B ACCESS Act, the reality is that 340B is a vital lifeline. 340B […]
